Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Oral Oncology|July 7, 2012
Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinomaNaito Kurio, Tsuyoshi Shimo, Takuya Fukazawa, et al.
Medical Hypotheses|August 8, 2006
Heparanase promotes angiogenesis through Cox-2 and HIF1alphaYoshio Naomoto, Mehmet Gunduz, Munenori Takaoka, et al.
Human Pathology|August 30, 2008
Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinomaKaiyo Takubo, Junko Aida, Yoshio Naomoto, et al.
Oncotarget|December 22, 2017
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinomaEtsuko Yokota, Tomoki Yamatsuji, Munenori Takaoka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases]Yasuhiro Fujiwara, Yoshio Naomoto, Shunsuke Tanabe, et al.
Oncology Reports|October 5, 2007
Microsatellite instability and clinicopathological features in esophageal squamous cell cancerYusuke Matsumoto, Takeshi Nagasaka, Takeshi Kambara, et al.
NPJ Precision Oncology|April 13, 2021
Clinical application of a lung cancer organoid (tumoroid) culture systemEtsuko Yokota, Miki Iwai, Takuro Yukawa, et al.
Molecular Cancer|January 3, 2024
Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profilesKazuya Yasui, Toshiaki Toshima, Ryo Inada, et al.
Oncology Reports|December 5, 2003
p53 expression and p21 expression are mutually exclusive in esophageal squamous cell carcinomaMadoka Hamada, Yoshio Naomoto, Yasuhiro Shirakawa, et al.
Experimental Cell Research|February 23, 2011
Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivoNaito Kurio, Tsuyoshi Shimo, Takuya Fukazawa, et al.
Pageof 14